Phosphoproteomics of osimertinib-tolerant persister cells reveals targetable kinase-substrate signatures.
Saved in:
| Title: | Phosphoproteomics of osimertinib-tolerant persister cells reveals targetable kinase-substrate signatures. |
|---|---|
| Authors: | Hsu HE; Institute of Chemistry, Academia Sinica, Taipei, Taiwan., Martin MJ; Oncology Targeted Discovery, Oncology R&D, AstraZeneca, Cambridge, UK., Weng SH; Institute of Chemistry, Academia Sinica, Taipei, Taiwan., Kitata RB; Institute of Chemistry, Academia Sinica, Taipei, Taiwan., Nagelli S; Oncology Targeted Discovery, Oncology R&D, AstraZeneca, Cambridge, UK., Chang CY; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Hess S; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. Sonja.Hess@astrazeneca.com., Chen YJ; Institute of Chemistry, Academia Sinica, Taipei, Taiwan. yujuchen@as.edu.tw.; Department of Chemistry, National Taiwan University, Taipei, Taiwan. yujuchen@as.edu.tw. |
| Source: | Molecular systems biology [Mol Syst Biol] 2025 Nov; Vol. 21 (11), pp. 1547-1562. Date of Electronic Publication: 2025 Sep 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101235389 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-4292 (Electronic) Linking ISSN: 17444292 NLM ISO Abbreviation: Mol Syst Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1744-4292 |
|---|---|
| DOI: | 10.1038/s44320-025-00141-1 |
